Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-12-21

Clinical Trial Update: Dexamethasone and Postoperative Delirium [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on dexamethasone for delirium and postoperative cognitive dysfunction has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DEXAMETHASONE (Dexamethasone)

Snippet

Sponsor: Endeavor Health | Conditions: Delirium, Postoperative Cognitive Dysfunction | Phase 4 | Status: TERMINATED